Filing Details
- Accession Number:
- 0000950103-23-001412
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-30 19:19:37
- Reporting Period:
- 2023-01-27
- Accepted Time:
- 2023-01-30 19:19:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1356090 | Precigen Inc. | PGEN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1886301 | Jr. Harry Thomasian | C/O Precigen, Inc. 20374 Seneca Meadows Parkway Germantown, MD 20876 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-01-27 | 28,571 | $1.75 | 84,961 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The reporting person purchased shares of Precigen common stock ("Common Stock") in connection with the issuer's follow-on offering, which closed on January 27, 2023. The purchase price is the offering price.
Billionaire Hedge Funds
